Addressing the mechanisms by which CBX3 contributes to lung cancer progression, particularly its involvement in cell proliferation, apoptosis regulation, and the modulation of key oncogenic pathways, will open novel avenues for therapeutic intervention. This evidence concerns the gene CBX3 and lung cancer.